← boardnext 2026-12
MDWD
MediWound Ltddistress 1/10 · well-funded / low risk$14.370%today-32% from 52w high
Lead: Venus Leg Ulcers
Revenue
pre-revenue
Liquidity
$53M
Runway
3.3 yrs
Shares 1y
0%
Price & events
-17.9% over 6M
CatalystRating changeDilutionFinancingdashed = today
-0.3%
1D
-1.6%
1W
+2.1%
1M
-13.7%
3M
-18.8%
6M
-31.6%
1Y
-26.9%
2Y
-47.4%
5Y
-45.5%
All
Overview
- Market Cap
- $184.44M
- Volume
- 2.35K
- 52 Week Range
- $13.73 – $21.00
- Total Shares
- 12.84M
- Float Shares
- 8.83M
- Short %
- 14.50%
- % Held by Insiders
- 15.86%
- % Held by Institutions
- 58.46%
- RVOL
- 0.03x
- Beta
- 0.14
Pipeline stages · 1 programs
EscharEx (EX-03)
Preclin›
Ph1›
Ph2›
Ph3›
Filed›
PDUFA›
Approved
Pipeline · 2 trials · 2 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| 2026-12 Estimated 50% readout ~2027-02-14 | Phase 3 | EscharEx (EX-03) | Venous Leg Ulcer (VLU) | — | recruiting |
| 2027-12-30 Estimated 50% readout ~2028-02-13 | Phase 2 | EscharEx (EX-03) | Venus Leg Ulcers | — | not yet recruiting |
Catalyst news & presentations · 1
- 2026-08-13Estimated 45%earningsEarningsEarnings releaseyahoo
Approved drugs (1)
- NEXOBRIDANACAULASE-BCDB2022 · Prescription
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- 2026-05-28HC Wainwright & Co.Buy
- 2026-05-28OppenheimerOutperform
- 2025-11-21HC Wainwright & Co.Buy
- 2025-05-22HC Wainwright & Co.Buy
- 2025-03-20HC Wainwright & Co.Buy
- 2025-02-28Craig-HallumBuy
Competitors — Venus Leg Ulcers
- none identified
Recent news
- 2026-07-22MediWound Ltd. Announces $30 Million Registered Direct Offering of Ordinary Shares - Quiver Quantitative
- 2026-07-20(MDWD) Volatility Zones as Tactical Triggers - Stock Traders Daily
- 2026-07-17Why is Cathie Wood’s ARK Fund Backing this Israeli Innovator? (NASDAQ: MDWD) - The Globe and Mail
- 2026-07-13MediWound Ltd. (MDWD) Q1 2026 Earnings: Narrowed Loss Beats Expectations, but Stock Slips - Earnings Season Preview - Bölüm Sonu Canavarı
- 2026-07-08(MDWD) Volatility Zones as Tactical Triggers - Stock Traders Daily
- 2026-07-04MediWound (MDWD) Stock Analysis Report | Ratings, Financials & Performance - Benzinga España
- 2026-07-01Enterprise value to revenue forward of MediWound Ltd. – FWB:M8W - TradingView
- 2026-06-29MediWound Ltd.(NasdaqGM: MDWD) added to Russell 2000 Growth-Defensive Index - marketscreener.com
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.